| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |